Edwards Lifesciences: Bobo sells 48,900 shares

The reported option holding was zero after the transaction; indirect holdings included 30,970 shares in a 401(k) and 98,611 shares by trust.

Available on EDGAR 11/09/2026 - 04:29 PM EST Accepted by SEC EDGAR 11/09/2026 - 04:29 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Donald E. Bobo Jr., CVP, Strategy/Corporate Development at Edwards Lifesciences Corp (EW), exercised 48,900 employee stock options on November 9, 2026, at a $72.68 exercise price and acquired 48,900 common shares. He also sold 48,900 shares at a weighted average of $103.0534 per share; both transactions were under a Rule 10b5-1 trading plan adopted February 12, 2026. The reported option holding was 0 shares afterward. Indirect holdings included 30,970 shares in a 401(k) and 98,611 shares by trust.

Insider Trade Summary 10b5-1

Exercise and Sale: 48,900 shares ($1.49M approx. pre-tax spread)

Exercise and Sale 3 txns

Insider BOBO DONALD E JR

Role CVP,Strategy/Corp Development

Sold 48,900 shs ($5.04M)

Approx. gross sale proceeds $5.04M

Approx. exercise cost $3.55M

Approx. pre-tax spread $1.49M

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option (Right to Acquire)	48,900	$0.00	$0.00
Exercise	Common Stock F1	48,900	$72.68	$3.55M
Sale	Common Stock F1, F2	48,900	$103.0534	$5.04M
Holding	Common Stock	--	--	--
Holding	Common Stock	--	--	--

Holdings After Transaction: Employee Stock Option (Right to Acquire) — 0 options (Direct); Common Stock — 22,798.2532 shares (Direct); Common Stock — 30,969.5756 shares (Indirect, 401(k)); Common Stock — 98,611 shares (Indirect, By Trust)

Footnotes (2)

1. F1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 12, 2026.
2. F2. This transaction was executed in multiple trades at prices ranging from $103.00 to $103.19. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Key Figures

Employee stock options exercised: 48,900 shares Exercise price: $72.68 per share Common shares sold: 48,900 shares +4 more

7 metrics

Employee stock options exercised 48,900 shares November 9, 2026

Exercise price $72.68 per share Options exercised November 9, 2026

Common shares sold 48,900 shares November 9, 2026

Weighted average sale price $103.0534 per share Sale executed in multiple trades on November 9, 2026

Reported option holding after transaction 0 shares November 9, 2026

Indirect 401(k) holdings 30,970 shares Reported November 9, 2026

Indirect trust holdings 98,611 shares Reported November 9, 2026

Key Terms

Rule 10b5-1 trading plan, weighted average sale price, exercise price

3 terms

Rule 10b5-1 trading plan regulatory

"transactions were effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"the price reported above reflects the weighted average sale price"

exercise price financial

"at an exercise price of $72.68 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many EW shares did Donald E. Bobo Jr. sell, and at what price?

Donald E. Bobo Jr. sold 48,900 shares on November 9, 2026, at a weighted average price of $103.0534 per share. The sale was executed in multiple trades at prices ranging from $103.00 to $103.19 under a Rule 10b5-1 trading plan adopted February 12, 2026.

What were the terms of Donald E. Bobo Jr.'s EW option exercise?

Bobo exercised 48,900 employee stock options on November 9, 2026, at an exercise price of $72.68 per share. The reported option holding was 0 shares afterward, and the option row lists an expiration date of May 6, 2027.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BOBO DONALD E JR

(Last) (First) (Middle)

ONE EDWARDS WAY

(Street)

IRVINE CALIFORNIA 92614

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Edwards Lifesciences Corp [ EW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CVP,Strategy/Corp Development

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/09/2026		M(1)		48,900	A	$72.68	71,698.2532	D
Common Stock	11/09/2026		S(1)		48,900	D	$103.0534(2)	22,798.2532	D
Common Stock								30,969.5756	I	401(k)
Common Stock								98,611	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Acquire)	$72.68	11/09/2026		M			48,900	06/07/2020	05/06/2027	Common Stock	48,900	$0.0000	0.0000	D

Explanation of Responses:

1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 12, 2026.

2. This transaction was executed in multiple trades at prices ranging from $103.00 to $103.19. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.

	Linda J. Park, Attorney-in-Fact	11/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)